About the Role
This position requires a dynamic individual who will partner with regional access leads to anticipate evidence needs from Health Technology Assessment (HTA) stakeholders across Europe. You will collaborate with internal cross-functional teams to gather and synthesize evidence for EU HTA-related projects, including PICO surveys and data consolidation.
Your primary focus will be on supporting the development of market access strategies and clinical development plans for Takeda’s oncology portfolio, with an emphasis on the evidence needs for HTA and payer stakeholders in Europe and Canada. You will co-lead the preparation and submission of EU Health Technology Assessment (HTA) documents, including Joint Clinical Assessments and Joint Scientific Consultations, ensuring compliance with EU Joint HTA guidelines and processes.
Furthermore, you will promote Takeda’s values and foster collaboration with cross-functional and global partners to enhance awareness and adoption of EU HTA evidence requirements.
How You Will Contribute
- Co-lead the strategy and development of high-quality HTA government submission dossiers for the European Union Joint Clinical Assessments (JCA) and Joint Scientific Consultations (JSC) for new oncology medicines.
- Collaborate with global and EUCAN Payer Value Access (PVA) leads to complete comprehensive HTA and payer evidence requirement mapping via PICO simulations for assigned assets, contributing to global development plans, statistical analysis plans, and evidence generation plans.
- As a key member of the Payer Value and Patient Access (PVPA) sub-team, represent the joint EU HTA archetype’s evidence needs in internal regional and global forums and communicate requirements and changes in joint HTA guidelines to inform the global brand, PVPA functional plan, and asset clinical development plans.
- In collaboration with the EUCAN Access Lead, co-lead Joint Scientific Consultations to collect feedback on clinical trial considerations and co-lead the EU JCA submission teams, leveraging expertise and collaborating closely with regional, global, and LOC members.
- Act as the primary contact for all JCA and JSC related evidence topics for assigned priority assets, interfacing with relevant internal partners, collaborators, and external stakeholders.
- Guide internal stakeholders regarding the methodological requirements and specifications for the EU HTA Regulation methods and processes to complement existing product area expertise.
- Maintain up-to-date knowledge of EU HTA guidelines, methods, and processes, communicating relevant updates to internal stakeholders.
- Understand trends and collaborations among national HTA/payers and regulatory agencies (EMA) with the EU HTA Coordination Group, providing strategic insights to global PVA. Shape EU joint HTA and reimbursement strategies based on these insights.
Education, Behavioral Competencies, and Skills
Required Qualifications:
- Minimum bachelor’s degree; an advanced/graduate degree (MSc, PhD, MPH, MPP, MBA) is preferred.
- A minimum of 6 years' experience in the biopharmaceutical industry or healthcare consulting.
- A minimum of 4 years' experience in market access, health economics, pricing, health policy, outcomes research, and/or consulting on these topics, showcasing increasing responsibility and experience in similar roles.
- Strong understanding of the EU payer and HTA environment, including HTA trends, reimbursement guidance, and technical methodologies (e.g., EU HTA, NICE, TLV, G-BA, HAS).
- Demonstrated advanced verbal and written communication, presentation, and influencing skills.
- Ability to manage complex projects with multiple stakeholders and work effectively under pressure.
- Solid knowledge of drug development processes and familiarity with global pharmaceutical cross-functional teams.
- Proven ability to navigate ambiguity and complex trade-offs in global discussions.
- Ability to frame HTA strategies and arguments and convert evidence into clear value messages for advocacy with stakeholders.
- Hands-on experience with health technology assessment tools, value materials, methods, and evidence synthesis approaches.
Preferred Qualifications:
- Advanced/graduate degree (MSc, PhD, MPH, MPP, MBA).
- Degree or diploma certificate in health economics or economic evaluations.
- Previous experience in Oncology.
- Experience in an above-country role (regional or global).
- Direct experience leading national HTA submissions or early scientific advice with HTA or regulatory agencies is a plus.
Travel Requirements
Up to 20% domestic and/or international travel may be required.
Additional Information
- Prior experience in assessing evidence needs for major HTA/payer stakeholders from EU5 and/or Canada.
- Excellent collaboration and communication skills with a proven track record in matrix environments.
- Experience in internal stakeholder management with a solution-oriented mindset.
- Strong understanding of the clinical development process.
Apply online using the form below.
Only applications matching the job profile will be considered.